β-Blocker use following myocardial infarction: Low prevalence of evidence-based dosing

Jeffrey J. Goldberger, Robert O Bonow, Michael Cuffe, Alan Richard Dyer, Yves Rosenberg, Robert O'Rourke, Prediman K. Shah, Sidney C. Smith

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'β-Blocker use following myocardial infarction: Low prevalence of evidence-based dosing'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science